Description
A-111 Recombinant ADAMTS13 as an effective therapy for acquired thrombotic thrombocytopenic purpura in rats
Article: A-111 Recombinant ADAMTS13 as an effective therapy for acquired thrombotic thrombocytopenic purpura in rats
€2.42
Related products
-
Article: INTRODUCTION
€2.42 Add to cart -
Article: Highlights in melanoma
€2.42 Add to cart -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€2.42 Add to cart -
Article: Highlights in breast cancer
€2.42 Add to cart
